Inspira Technologies OXY B.H.N. Ltd. has regained compliance with Nasdaq Listing Rule 5550(a)(2) by maintaining a closing bid price of $1.00 per share for 10 consecutive business days. CEO Dagi Ben-Noon expressed confidence in the company’s strategic trajectory, citing recent achievements such as securing a large commercial order and forming government partnerships. Inspira is focusing on global distribution and delivering long-term value to shareholders. The company’s advancements in government-focused strategy, clinical integration, manufacturing capabilities, and recent purchase order have positioned it for accelerated discussions with commercial and governmental entities worldwide. Inspira Technologies specializes in advanced respiratory support and real-time blood monitoring solutions.

Read more at GlobeNewswire: Inspira Regains Compliance with Nasdaq Minimum Bid Price